Abstract
Ion channels allow the passage of specific ions and electrical charge. Plasma membrane channels are, for example, important for electrical excitability and transepithelial transport, whereas intracellular channels have roles in acidifying endosomes or in releasing Ca2+ from stores. The function of several channels emerged from mutations in humans or mice. The resulting phenotypes include kidney stones resulting from impaired endocytosis, hypertension, defective insulin secretion, cardiac arrhythmias, neurological diseases like epilepsy or deafness and even 'developmental' defects such as osteopetrosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hübner, C. A. & Jentsch, T. J. Ion channel diseases. Hum. Mol. Genet. 11, 2435–2445 (2002).
Ashcroft, F. M. Ion channels and disease (Academic Press, San Diego, 2000).
Riordan, J. R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066–1073 (1989).
Smith, J. J., Travis, S. M., Greenberg, E. P. & Welsh, M. J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229–236 (1996).
Goldman, M. J. et al. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553–560 (1997).
Barasch, J. et al. Defective acidification of intracellular organelles in cystic fibrosis. Nature 352, 70–73 (1991).
Pier, G. B. et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393, 79–82 (1998).
Stutts, M. J. et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 269, 847–850 (1995).
Reddy, M. M., Light, M. J. & Quinton, P. M. Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl− channel function. Nature 402, 301–304 (1999).
Nagel, G., Szellas, T., Riordan, J. R., Friedrich, T. & Hartung, K. Non-specific activation of the epithelial sodium channel by the CFTR chloride channel. EMBO Rep. 2, 249–254 (2001).
Schwiebert, E. M. et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 81, 1063–1073 (1995).
McNicholas, C. M. et al. Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator. Proc. Natl Acad. Sci. USA 93, 8083–8088 (1996).
Mall, M., Grubb, B. R., Harkema, J. R., O'Neal, W. K. & Boucher, R. C. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nature Med. 10, 487–493 (2004).
Ko, S. B. et al. Gating of CFTR by the STAS domain of SLC26 transporters. Nature Cell Biol. 6, 343–350 (2004).
Schild, L. et al. Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J. 15, 2381–2387 (1996).
Staub, O. et al. Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J. 16, 6325–6336 (1997).
Debonneville, C. et al. Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na+ channel cell surface expression. EMBO J. 20, 7052–7059 (2001).
Wulff, P. et al. Impaired renal Na+ retention in the sgk1-knockout mouse. J. Clin. Invest. 110, 1263–1268 (2002).
Chang, S. S. et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nature Genet. 12, 248–253 (1996).
Wilson, F. H. et al. Human hypertension caused by mutations in WNK kinases. Science 293, 1107–1112 (2001).
Wilson, F. H. et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na–Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc. Natl Acad. Sci. USA 100, 680–684 (2003).
Yang, C. L., Angell, J., Mitchell, R. & Ellison, D. H. WNK kinases regulate thiazide-sensitive Na–Cl cotransport. J. Clin. Invest. 111, 1039–1045 (2003).
Kahle, K. T. et al. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nature Genet. 35, 372–376 (2003).
Simon, D. B. et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2Cl cotransporter NKCC2. Nature Genet. 13, 183–188 (1996).
Simon, D. B. et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nature Genet. 17, 171–178 (1997).
Birkenhäger, R. et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nature Genet. 29, 310–314 (2001).
Estévez, R. et al. Barttin is a Cl−-channel β-subunit crucial for renal Cl−-reabsorption and inner ear K+-secretion. Nature 414, 558–561 (2001).
Neyroud, N. et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange–Nielsen cardioauditory syndrome. Nature Genet. 15, 186–189 (1997).
Schulze-Bahr, E. et al. KCNE1 mutations cause Jervell and Lange–Nielsen syndrome. Nature Genet. 17, 267–268 (1997).
Kubisch, C. et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96, 437–446 (1999).
Schlingmann, K. P. et al. Salt wasting and deafness resulting from mutations in two chloride channels. N. Engl. J. Med. 350, 1314–1319 (2004).
Schlingmann, K. P. et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nature Genet. 31, 166–170 (2002).
Simon, D. B. et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285, 103–106 (1999).
Van Itallie, C., Rahner, C. & Anderson, J. M. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J. Clin. Invest. 107, 1319–1327 (2001).
Yamauchi, K. et al. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc. Natl Acad. Sci. USA 101, 4690–4694 (2004).
Wang, Q. et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80, 805–811 (1995).
Wang, Q. et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genet. 12, 17–23 (1996).
Splawski, I., Tristani-Firouzi, M., Lehmann, M. H., Sanguinetti, M. C. & Keating, M. T. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nature Genet. 17, 338–340 (1997).
Curran, M. E. et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80, 795–803 (1995).
Abbott, G. W. et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97, 175–187 (1999).
Koch, M. C. et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257, 797–800 (1992).
Ptacek, L. J. et al. Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 8, 891–897 (1992).
Ptacek, L. J. et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67, 1021–1027 (1991).
Biervert, C. et al. A potassium channel mutation in neonatal human epilepsy. Science 279, 403–406 (1998).
Charlier, C. et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nature Genet. 18, 53–55 (1998).
Escayg, A. et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+. Nature Genet. 24, 343–345 (2000).
Wallace, R. H. et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel b1 subunit gene SCN1B. Nature Genet. 19, 366–370 (1998).
Sugawara, T. et al. A missense mutation of the Na+ channel aII subunit gene Na v 1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc. Natl Acad. Sci. USA 98, 6384–6389 (2001).
Plaster, N. M. et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105, 511–519 (2001).
Bennett, P. B., Yazawa, K., Makita, N. & George, A. L. Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 376, 683–685 (1995).
Wang, D. W., Yazawa, K., George, A. L. Jr. & Bennett, P. B. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc. Natl Acad. Sci. USA 93, 13200–13205 (1996).
Chahine, M. et al. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation. Neuron 12, 281–294 (1994).
Cannon, S. C., Brown, R. H., Jr. & Corey, D. P. A sodium channel defect in hyperkalemic periodic paralysis: potassium-induced failure of inactivation. Neuron 6, 619–626 (1991).
McClatchey, A. I. et al. Temperature-sensitive mutations in the III–IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell 68, 769–774 (1992).
Bulman, D. E. et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53, 1932–1936 (1999).
Ptacek, L. J. et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77, 863–868 (1994).
Jurkat-Rott, K. et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum. Mol. Genet. 3, 1415–1419 (1994).
Abbott, G. W. et al. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104, 217–231 (2001).
Schroeder, B. C. et al. A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature 403, 196–199 (2000).
Sternberg, D., Tabti, N., Fournier, E., Hainque, B. & Fontaine, B. Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis. Neurology 61, 857–859 (2003).
Jurkat-Rott, K. & Lehmann-Horn, F. Periodic paralysis mutation MiRP2–R83H in controls: Interpretations and general recommendation. Neurology 62, 1012–1015 (2004).
Steinmeyer, K. et al. Inactivation of muscle chloride channel by transposon insertion in myotonic mice. Nature 354, 304–308 (1991).
Pusch, M., Steinmeyer, K., Koch, M. C. & Jentsch, T. J. Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the ClC-1 chloride channel. Neuron 15, 1455–1463 (1995).
Berkovic, S. F. et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann. Neurol. 55, 550–557 (2004).
Browne, D. L. et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nature Genet. 8, 136–140 (1994).
Ophoff, R. A. et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543–552 (1996).
Lossin, C., Wang, D. W., Rhodes, T. H., Vanoye, C. G. & George, A. L. Jr. Molecular basis of an inherited epilepsy. Neuron 34, 877–884 (2002).
Schroeder, B. C., Kubisch, C., Stein, V. & Jentsch, T. J. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature 396, 687–690 (1998).
Wang, H. S. et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282, 1890–1893 (1998).
Wallace, R. H. et al. Mutant GABAA receptor g2-subunit in childhood absence epilepsy and febrile seizures. Nature Genet. 28, 49–52 (2001).
Baulac, S. et al. First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the g2-subunit gene. Nature Genet. 28, 46–48 (2001).
Cossette, P. et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nature Genet. 31, 184–189 (2002).
Shiang, R. et al. Mutations in the a1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genet. 5, 351–358 (1993).
Hübner, C.A. et al. Disruption of KCC2 reveals an essential role of K–Cl-cotransport already in early synaptic inhibition. Neuron 30, 515–524 (2001).
Bösl, M. R. et al. Male germ cells and photoreceptors, both depending on close cell–cell interactions, degenerate upon ClC-2 Cl−-channel disruption. EMBO J. 20, 1289–1299 (2001).
Haug, K. et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nature Genet. 33, 527–532 (2003).
Niemeyer, M. I. et al. Functional evaluation of human ClC-2 chloride channel mutations associated with idiopathic generalized epilepsies. Physiol. Genom. 19, 74–83 (2004).
Thomas, P. M. et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268, 426–429 (1995).
Thomas, P., Ye, Y. & Lightner, E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum. Mol. Genet. 5, 1809–1812 (1996).
Gloyn, A. L. et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 350, 1838–1849 (2004).
Zerangue, N., Schwappach, B., Jan, Y. N. & Jan, L. Y. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane KATP channels. Neuron 22, 537–548 (1999).
Gloyn, A. L. et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52, 568–572 (2003).
Lloyd, S. E. et al. A common molecular basis for three inherited kidney stone diseases. Nature 379, 445–449 (1996).
Piwon, N., Günther, W., Schwake, M., Bösl, M. R. & Jentsch, T. J. ClC-5 Cl−-channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408, 369–373 (2000).
Stobrawa, S. M. et al. Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron 29, 185–196 (2001).
Kornak, U. et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205–215 (2001).
Günther, W., Lüchow, A., Cluzeaud, F., Vandewalle, A. & Jentsch, T. J. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc. Natl Acad. Sci. USA 95, 8075–8080 (1998).
Günther, W., Piwon, N. & Jentsch, T. J. The ClC-5 chloride channel knock-out mouse – an animal model for Dent's disease. Pflügers Arch. 445, 456–462 (2003).
Cleiren, E. et al. Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the CLCN7 chloride channel gene. Hum. Mol. Genet. 10, 2861–2867 (2001).
Greene, J. R., Brown, N. H., DiDomenico, B. J., Kaplan, J. & Eide, D. J. The GEF1 gene of Saccharomyces cerevisiae encodes an integral membrane protein; mutations in which have effects on respiration and iron-limited growth. Mol. Gen. Genet. 241, 542–553 (1993).
Schwappach, B., Stobrawa, S., Hechenberger, M., Steinmeyer, K. & Jentsch, T. J. Golgi localization and functionally important domains in the NH2 and COOH terminus of the yeast CLC putative chloride channel Gef1p. J. Biol. Chem. 273, 15110–15118 (1998).
Gaxiola, R. A., Yuan, D. S., Klausner, R. D. & Fink, G. R. The yeast CLC chloride channel functions in cation homeostasis. Proc. Natl Acad. Sci. USA 95, 4046–4050 (1998).
Davis-Kaplan, S. R., Askwith, C. C., Bengtzen, A. C., Radisky, D. & Kaplan, J. Chloride is an allosteric effector of copper assembly for the yeast multicopper oxidase Fet3p: an unexpected role for intracellular chloride channels. Proc. Natl Acad. Sci. USA 95, 13641–13645 (1998).
Maranda, B. et al. Intra-endosomal pH-sensitive recruitment of the Arf-nucleotide exchange factor ARNO and Arf6 from cytoplasm to proximal tubule endosomes. J. Biol. Chem. 276, 18540–18550 (2001).
Fujii, J. et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253, 448–451 (1991).
Gillard, E. F. et al. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 11, 751–755 (1991).
Priori, S. G. et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103, 196–200 (2001).
Tiso, N. et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10, 189–194 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jentsch, T., Hübner, C. & Fuhrmann, J. Ion channels: Function unravelled by dysfunction. Nat Cell Biol 6, 1039–1047 (2004). https://doi.org/10.1038/ncb1104-1039
Issue Date:
DOI: https://doi.org/10.1038/ncb1104-1039
This article is cited by
-
Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach
Biochemical Genetics (2023)
-
The Role οf Ion Channels in the Development and Progression of Prostate Cancer
Molecular Diagnosis & Therapy (2023)
-
Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry
Signal Transduction and Targeted Therapy (2022)
-
Ratio of Hydrophobic–Hydrophilic and Positive–Negative Residues at Lipid–Water-Interface Influences Surface Expression and Channel Gating of TRPV1
The Journal of Membrane Biology (2022)
-
Multiscale real time and high sensitivity ion detection with complementary organic electrochemical transistors amplifier
Nature Communications (2020)